In lung adenocarcinoma, POLR2A expression strongly correlates with BCAR1 (breast cancer antiestrogen resistance protein 1) overexpression and with unfavorable clinical outcomes (Mao et al., 2020). Here, BCAR1 is linked to lung adenocarcinoma.